In vitro proof of concept

Nanotraps for the containment and clearance of SARS-CoV-2

SUMMARY Inventors devised a nanomedicine termed “Nanotraps” that can completely capture and eliminate SARS-CoV-2 by triggering macrophages to engulf and clear the virus without becoming infected. Ex vivo lung perfusion system. Zero toxicity was found in mice as evidenced by histological analysis of heart, liver, spleen, lung, and kidney, as… Read More

Monolithic (Binder Free) Carbon-Based Bioelectronic Devices for Biomodulation and Electroceutical Applications

SUMMARY The global electroceuticals market is expected to reach $25+ billion by 2021.  Modern biolectronics with multi-scale structures are used extensively for drug delivery, biosensing, and biological modulations.  However, macroscopic bioelectronic devices are usually rigid and mechanically invasive to cells and tissues.  Therefore, nanostructuring of the bioelectronics surfaces represents a… Read More

Residual Bubble Control to Boost Ablative Ultrasound Efficacy

SUMMARY Residual bubble clouds decrease the therapeutic efficacy of ablative ultrasound therapy. Ultrasound pulses can be used to destroy residual bubbles, however constructive interference limits simultaneous imaging and monitoring. The inventors developed a method to use plane wave B-mode imaging for the simultaneous generation of bubble deleting pulses and real… Read More

Rad51 Inhibitors for Sensitization to Chemotherapy and Radiation

SUMMARY Optimized small-molecule inhibitors of RAD51 that selectively suppress D-loop formation and homologous recombination The Unmet Need: Selective agents that suppress homologous recombination repair without off-target toxicity. RAD51 is a central protein in homologous recombination, a DNA repair pathway that helps cells repair double-strand breaks accurately. Many tumors overexpress RAD51… Read More

FOXP3 Stapled Peptides to Deactivate Regulatory T Cells

SUMMARY Regulatory T cells (Tregs) modulate immune function by preventing autoreactive T cell responses, including those that would normally target cancer cells. Treg activity can significantly limit the efficacy of immunotherapies designed to stimulate CD8+ T cells, and therefore a strategy for reducing Treg activity as an aspect of immunotherapy… Read More

Novel Aqueous Chemical Stabilization Method for Proteins Based on the Diels-alder Reaction

SUMMARY Stabilization of therapeutic proteins and peptides is often necessary to improve pharmacokinetic properties and reduce proteolysis in vivo. However, pre-existing stabilization strategies require expensive catalysts or harsh reagents that prevent preservation of certain sterically challenging protein structures. The inventors found that the Diels-Alder reaction, when performed aqueously or in… Read More

Activity-responsive Split RNA Polymerase Platform for Biosensors and Gene Therapy

SUMMARY An understanding of protein-protein interactions (PPIs) is critical to uncovering new disease pathophysiology and for developing small molecule and antibody treatments. Problematically, current approaches to assay PPIs are limited by sensitivity, signal to noise ratio, and the need to carefully optimize the assay for each new application. The inventors… Read More